BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30862812)

  • 1. Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic.
    Barrett TC; Mok WWK; Murawski AM; Brynildsen MP
    Nat Commun; 2019 Mar; 10(1):1177. PubMed ID: 30862812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
    Völzing KG; Brynildsen MP
    mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of DNA damage responses impacts persistence to fluoroquinolones.
    Mok WWK; Brynildsen MP
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6301-E6309. PubMed ID: 29915065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of oxidative stress in persister tolerance.
    Wu Y; Vulić M; Keren I; Lewis K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4922-6. PubMed ID: 22777047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance acquired through a DNA damage-inducible response in Acinetobacter baumannii.
    Norton MD; Spilkia AJ; Godoy VG
    J Bacteriol; 2013 Mar; 195(6):1335-45. PubMed ID: 23316046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin.
    Bernier SP; Lebeaux D; DeFrancesco AS; Valomon A; Soubigou G; Coppée JY; Ghigo JM; Beloin C
    PLoS Genet; 2013; 9(1):e1003144. PubMed ID: 23300476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell imaging and characterization of
    Goormaghtigh F; Van Melderen L
    Sci Adv; 2019 Jun; 5(6):eaav9462. PubMed ID: 31223653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOS response induces persistence to fluoroquinolones in Escherichia coli.
    Dörr T; Lewis K; Vulić M
    PLoS Genet; 2009 Dec; 5(12):e1000760. PubMed ID: 20011100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine blocks SOS induction and mutagenesis produced by fluoroquinolones in Escherichia coli.
    Rodríguez-Rosado AI; Valencia EY; Rodríguez-Rojas A; Costas C; Galhardo RS; Rodríguez-Beltrán J; Blázquez J
    J Antimicrob Chemother; 2019 Aug; 74(8):2188-2196. PubMed ID: 31102529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance of Escherichia coli to fluoroquinolone antibiotics depends on specific components of the SOS response pathway.
    Theodore A; Lewis K; Vulic M
    Genetics; 2013 Dec; 195(4):1265-76. PubMed ID: 24077306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of SOS response expression in clinical isolates of Escherichia coli influences adaptation to antimicrobial stress.
    Diaz-Diaz S; Garcia-Montaner A; Vanni R; Murillo-Torres M; Recacha E; Pulido MR; Romero-Muñoz M; Docobo-Pérez F; Pascual A; Rodriguez-Martinez JM
    Drug Resist Updat; 2024 Jul; 75():101087. PubMed ID: 38678745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.
    Dörr T; Vulić M; Lewis K
    PLoS Biol; 2010 Feb; 8(2):e1000317. PubMed ID: 20186264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamblers: An Antibiotic-Induced Evolvable Cell Subpopulation Differentiated by Reactive-Oxygen-Induced General Stress Response.
    Pribis JP; García-Villada L; Zhai Y; Lewin-Epstein O; Wang AZ; Liu J; Xia J; Mei Q; Fitzgerald DM; Bos J; Austin RH; Herman C; Bates D; Hadany L; Hastings PJ; Rosenberg SM
    Mol Cell; 2019 May; 74(4):785-800.e7. PubMed ID: 30948267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational regulation of Escherichia coli DNA polymerase V by RecA and ATP.
    Jaszczur MM; Vo DD; Stanciauskas R; Bertram JG; Sikand A; Cox MM; Woodgate R; Mak CH; Pinaud F; Goodman MF
    PLoS Genet; 2019 Feb; 15(2):e1007956. PubMed ID: 30716079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ploidy is an important determinant of fluoroquinolone persister survival.
    Murawski AM; Brynildsen MP
    Curr Biol; 2021 May; 31(10):2039-2050.e7. PubMed ID: 33711253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair.
    VandenBerg KE; Ahn S; Visick JE
    Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of RecA activity discovered by high-throughput screening: cell-permeable small molecules attenuate the SOS response in Escherichia coli.
    Wigle TJ; Sexton JZ; Gromova AV; Hadimani MB; Hughes MA; Smith GR; Yeh LA; Singleton SF
    J Biomol Screen; 2009 Oct; 14(9):1092-101. PubMed ID: 19675313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment.
    Hare PJ; Englander HE; Mok WWK
    J Appl Microbiol; 2022 Jun; 132(6):4020-4032. PubMed ID: 35332984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli.
    Recacha E; Machuca J; Díaz-Díaz S; García-Duque A; Ramos-Guelfo M; Docobo-Pérez F; Blázquez J; Pascual A; Rodríguez-Martínez JM
    J Antimicrob Chemother; 2019 Jan; 74(1):66-73. PubMed ID: 30329046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the links between SOS response, mutagenesis, and resistance during the recovery period.
    Ghosh S; Orman MA
    Antimicrob Agents Chemother; 2024 May; 68(5):e0146223. PubMed ID: 38534113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.